Evidence map›Paper›PMID 32439331›Full record

ArticleJournal of molecular biology2020

Yeast Spt6 Reads Multiple Phosphorylation Patterns of RNA Polymerase II C-Terminal Domain In Vitro.

Pavel Brázda, Magdaléna Krejčíková, Aiste Kasiliauskaite, Eliška Šmiřáková, Tomáš Klumpler, Robert Vácha, Karel Kubíček, Richard Štefl

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pavel BrázdaCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Magdaléna KrejčíkováCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Aiste KasiliauskaiteCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Eliška ŠmiřákováCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Tomáš KlumplerCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Robert VáchaCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Karel KubíčekCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic.
Richard ŠteflCEITEC-Central European Institute of Technology, Masaryk University, CZ-62500 Brno, Czech Republic. Electronic address: richard.stefl@ceitec.muni.cz.
Central European Institute of Technology – Masaryk University · CZCentral European Institute of Technology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcription elongation factor Spt6 associates with RNA polymerase II (RNAP II) via a tandem SH2 (tSH2) domain. The mechanism and significance of the RNAP II-Spt6 interaction is still unclear. Recently, it was proposed that Spt6-tSH2 is recruited via a newly described phosphorylated linker between the Rpb1 core and its C-terminal domain (CTD). Here, we report binding studies with isolated tSH2 of Spt6 (Spt6-tSH2) and Spt6 lacking the first unstructured 297 residues (Spt6ΔN) with a minimal CTD substrate of two repetitive heptads phosphorylated at different sites. The data demonstrate that Spt6 also binds the phosphorylated CTD, a site that was originally proposed as a recognition epitope. We also show that an extended CTD substrate harboring 13 repetitive heptads of the tyrosine-phosphorylated CTD binds Spt6-tSH2 and Spt6ΔN with tighter affinity than the minimal CTD substrate. The enhanced binding is achieved by avidity originating from multiple phosphorylation marks present in the CTD. Interestingly, we found that the steric effects of additional domains in the Spt6ΔN construct partially obscure the binding of the tSH2 domain to the multivalent ligand. We show that Spt6-tSH2 binds various phosphorylation patterns in the CTD and found that the studied combinations of phospho-CTD marks (1,2; 1,5; 2,4; and 2,7) all facilitate the interaction of CTD with Spt6. Our structural studies reveal a plasticity of the tSH2 binding pockets that enables the accommodation of CTDs with phosphorylation marks in different registers.

Indexed as

Transcription, GeneticAmino Acid SequenceEpitopesHistone ChaperonesPhosphorylationProtein BindingRNA Polymerase IISaccharomyces cerevisiaeSaccharomyces cerevisiae Proteinssrc Homology DomainsTranscriptional Elongation FactorsEpitopesHistone ChaperonesRNA Polymerase IISaccharomyces cerevisiae ProteinsSPT6 protein, S cerevisiaeTranscriptional Elongation FactorsCTDphosphorylationRNA polymerase IISpt6, NMR structure

Identifiers

PMID32439331
PMCPMC7327521
OpenAlexW3026425519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.